Organization (Academic)
University of Messina
ClinicalTrials.gov lists University of Messina as lead sponsor of 53 trials. It has 5 active development programs and 7 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers University of Messina: 53 lead-sponsored trials and 1 legal-entity registration.
Disease areas (87)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Diabetes Mellitus | 8 |
| Insulin Resistance | 8 |
| Metabolic Syndrome | 5 |
| Cardiomyopathies | 4 |
| Diabetes, Gestational | 4 |
Showing 5 of 87 disease areas.
Trials by start year as sponsor or collaborator (24)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 6 |
| 2024 | 6 |
| 2023 | 5 |
| 2022 | 2 |
| 2021 | 8 |
| 2020 | 4 |
| 2019 | 5 |
| 2018 | 8 |
| 2017 | 3 |
Showing 10 of 24 years.
Recruitment duration, a model prediction: none of the 53 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (5)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Clopidogrel + Aspirin for CCS patients | Myocardial Infarction | Not reported | 1 |
| Clopidogrel + Aspirin for CCS patients | Ventricular Remodeling | Not reported | 1 |
| P2Y12 Potent Inhibitor + Aspirin for STEMI patients | Myocardial Infarction | Not reported | 1 |
| P2Y12 Potent Inhibitor + Aspirin for STEMI patients | Ventricular Remodeling | Not reported | 1 |
| Alpha Lipoic Acid | Schizophrenia | Not reported | 1 |
Approved assets (7)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| NACL 0.9% | 1 |
| Clopidogrel 75 mg | 1 |
| Ticagrelor 60 mg | 1 |
| Polydeoxyribonucleotide | 1 |
| MELATONIN | 1 |
Showing 5 of 7 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 60% hit target (n=5) | 67% on time (n=6) |
Journals published in (134)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Journal of the American College of Cardiology | 7 |
| The Cochrane database of systematic reviews | 5 |
| The Journal of arthroplasty | 5 |
| JAMA | 4 |
| Menopause (New York, N.Y.) | 4 |
Showing 5 of 134 journals.
Organization relationships (40)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Istituti di Ricovero e Cura a Carattere Scientifico | Co sponsors trial with | 4 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Co sponsors trial with | 3 |
| Ospedale Meyer | Co sponsors trial with | 2 |
| IRCCS Fondazione Stella Maris | Co sponsors trial with | 2 |
| Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | Co sponsors trial with | 2 |
Showing 5 of 40 relationships.
Latest dated events (87)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-11-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-01-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-10-20 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-06-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 87 events.
Biomarker capability evidence (54)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ARC | Trial sponsor | Named in trial inclusion criteria |
| BCAR1 | Trial collaborator | Named in trial inclusion criteria |
| CSE1L | Trial collaborator | Named in trial inclusion criteria |
| DMD | Trial sponsor | Named in trial inclusion criteria |
| DMD | Trial collaborator | Named in trial inclusion criteria |
Showing 5 of 54 evidence rows.
Biomarkers this organization publishes on (762)
Shown in this order: most publications first.
Showing 5 of 762 biomarkers.
On Scientist.com
University of Messina is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with University of Messina (Universita Degli Studi di Messina) on Scientist.com
For prices, more details, or to contact University of Messina (Universita Degli Studi di Messina), visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.